Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
| Id | http://purl.obolibrary.org/obo/NCIT_C1494
http://purl.obolibrary.org/obo/NCIT_C1494
|
|---|---|
| Preferred Name | Arcitumomab |
| Definitions |
A murine IgG monoclonal Fab' fragment antibody directed against carcinoembryonic antigen (CEA), a protein that is overexpressed by many tumor cell types. For tumors that overexpress CEA, technetium-99m labeled arcitumomab may be used as an adjunct diagnostic imaging tool to obtain prognostic information following resection and to monitor for recurrent disease. (NCI04)
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| definition | A murine IgG monoclonal Fab' fragment antibody directed against carcinoembryonic antigen (CEA), a protein that is overexpressed by many tumor cell types. For tumors that overexpress CEA, technetium-99m labeled arcitumomab may be used as an adjunct diagnostic imaging tool to obtain prognostic information following resection and to monitor for recurrent disease. (NCI04) |
|---|---|
| prefLabel | Arcitumomab
|
| label | Arcitumomab
|
| NCI_META_CUI | CL938206
|
| PDQ_Closed_Trial_Search_ID | 42612
|
| code | C1494
|
| prefixIRI | NCIT:C1494
|
| in_subset | |
| Preferred_Name | Arcitumomab
|
| FDA_UNII_Code | 79T6JRG308
|
| Contributing_Source | FDA
|
| Maps_To | Arcitumomab
|
| CAS_Registry | 154361-48-5
|
| NCI_Drug_Dictionary_ID | 42612
|
| Legacy Concept Name | Arcitumomab
|
| type | |
| Is_Value_For_GDC_Property | |
| subClassOf | |
| PDQ_Open_Trial_Search_ID | 42612
|
| Accepted_Therapeutic_Use_For | Colorectal carcinoma and medullary thyroid carcinoma detection
|
| Semantic_Type |
Amino Acid, Peptide, or Protein
Pharmacologic Substance
Immunologic Factor
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |